Status:
UNKNOWN
An Observational Study to Evaluate Lymph Metastases and Prognoses of the Patients With Esophageal Cancer
Lead Sponsor:
Henan Cancer Hospital
Collaborating Sponsors:
LinkDoc Technology (Beijing) Co. Ltd.
Conditions:
Esophageal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The real-world observational study was designed to explore lymph metastases and prognoses of the Chinese patients with thoracic T1-T3 esophageal cancer
Detailed Description
This trial is a real-world non-interventional observational study. The Chinese patients with thoracic T1-T3 esophageal cancer enrolled from Jan.1999 to Jun.2017 were included and the study data on pat...
Eligibility Criteria
Inclusion
- Patients \>= 18 years old;
- Patients who received radical resection of esophageal cancer;
- Pathologically diagnosed patients with thoracic T1-T3 esophageal cancer after surgeries;
Exclusion
- Patients who received upper gastrointestinal surgeries;
- Patients with second primary tumors;
Key Trial Info
Start Date :
December 12 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2018
Estimated Enrollment :
3673 Patients enrolled
Trial Details
Trial ID
NCT03415815
Start Date
December 12 2017
End Date
April 30 2018
Last Update
January 30 2018
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China, 100029
2
China PLA General Hospital
Beijing, Beijing Municipality, China, 100853
3
Henan cancer hospital
Zhengzhou, Henan, China, 450008
4
Tongji Hospital Affiliated to Huazhong Technology Hospital
Wuhan, Hubei, China, 430030